Artemis Medicare Services Ltd (ARTEMISMED) โ Announcement | 29 September 2026
Artemis Medicare Services Ltd disclosed a GST show cause notice dated September 28, 2026 from the Assistant Commissioner, CGST Gurugram concerning alleged overcharging of MRP on medicines and consumables for in-patients during FY2022-23. The filing confirms the company is filing a writ petition to connect this matter with a prior pending case where the High Court had stayed proceedings. Annexure A quantifies potential financial implications at Rs. 11.11 Crore plus interest and penalty, though no penalty has been imposed yet. The company previously disclosed similar litigation on November 22, 2024, and secured an interim stay in that case. This regulatory update signals ongoing tax compliance scrutiny but no immediate financial liability.
About Artemis Medicare Services Ltd (ARTEMISMED)
Healthcare ยท Healthcare ยท Listed on BSE
๐ก Get AI alerts when ARTEMISMED files next
Free โข Daily 5 PM digest โข Track filings, board meetings, and corporate actions
Track ARTEMISMED โ Free๐ก Ask AI about this filing
๐ More ARTEMISMED filings
- Announcement โ 28 September 2026Artemis Medicare Services Ltd announced that its trading window will close on October 1, 2026, and r...
- ๐ด Announcement โ 24 September 2026Artemis Medicare Services Ltd received a credit rating reaffirmation from CARE Ratings on September ...
- ๐ด Announcement โ 8 September 2026Artemis Medicare Services Ltd announced its participation in the Anand Rathi Annual Flagship Confere...
- ๐ด Announcement โ 27 August 2026Artemis Medicare Services Ltd announced its upcoming investor conference scheduled for September 3, ...
- ๐ด Financial Results โ 10 August 2026Artemis Medicare Services Limited reported **โน287.32 crores** revenue with **48.3% PAT growth** to *...
๐ฅ Also filed on 29 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only โ not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
๐ก Get AI alerts when ARTEMISMED files new disclosures
Track ARTEMISMED filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ARTEMISMED โ FreeFree account ยท 2 AI queries/day